home  about  experts  links
MPT WWW
 

MedicalProgressToday is a web magazine devoted to chronicling how market-friendly public policies drive life-saving medical innovations and make health care more affordable and accessible for all Americans.

 
 

MPT Podcasts



PODCAST:
Tomas Philipson, chairman of the Manhattan Institute’s Project FDA, professor at the Harris School for Public Policy at the University of Chicago, former Bush Administration Senior Economic Advisor to the head of the Food and Drug Administration (FDA) during 2003-04, and Senior Economic Advisor to the head of the Centers for Medicare and Medicaid Services (CMS) in 2004-05, talks to Paul Howard about comparative effectiveness research

Recommended Reading:
The Blue Pill Or The Red Pill?, Tomas Philipson, Forbes.com, 1-14-10
The Impact of Comparative Effectiveness Research on Health and Health Care Spending, Anirban Basu, Tomas J. Philipson, January 2010



PODCAST:
Richard Amerling, MD, Director of Outpatient Dialysis at Beth Israel Medical Center in New York, Associate Professor of Clinical Medicine at Albert Einstein College of Medicine, and a Director of the Association of American Physicians and Surgeons, talks to Paul Howard, director of the Center for Medical Progress at the Manhattan Institute, about impending severe cuts in funding for dialysis due to take effect in January, 2011. Dr. Amerling says these cuts will lead to rationing of certain medicines used currently for these patients, and may force some dialysis units out of business.

Recommended Reading:
Doctors Are Like Frogs Being Slowly Boiled, Richard Amerling, Wall Street Journal Letter to the Editor, 11-3-09

Recommended Links:
What do doctors fear the most about Obama Care?, NewsMax.TV
AAPS Director and Member on Glenn Beck Show, Fox News



PODCAST:
Paul Offit, MD, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia. Dr. Offit is also the Maurice R. Hilleman Professor of Vaccinology, and a Professor of Pediatrics at the University of Pennsylvania School of Medicine, talks to Paul Howard, director of the Center for Medical Progress, about seasonal flu vaccines and shortages, H1N1, and what lessons we can learn from our first brush with a global pandemic since the U.S. began upgrading its capacity to produce vaccine and respond to flu pandemics several years ago.

Recommended Reading:
Inoculated Against Facts, Paul Offit, New York Times, 3-31-08
Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure, Paul Offit, September 2008



PODCAST:
David Gratzer, senior fellow at the Manhattan Institute, talks to Paul Howard, director of the Center for Medical Progress, about his new broadside, “Why Obama’s government takeover of health care will be a disaster”


"Some countries spend less on healthcare but the way they have gone about doing that is by rationing care- everything is free, nothing is readily available." – David Gratzer

Recommended Reading:
"Why Obama’s government takeover of health care will be a disaster", David Gratzer, Encounter Books, November 2009



PODCAST:
Mary Kate Scott, founder and CEO of Scott & Co, talks to Paul Howard, director of the Center for Medical Progress, about the retail clinic model and what the future of the model may hold for consumer-driven health care.


"They have looked at healthcare from the consumer or the patients point of view and have thought about what is it that that patient would really like to experience in healthcare?" – Mary Kate Scott

LINKS:
www.MaryKateScott.com



PODCAST:
Stephen T. Parente, Academic Director, Medical Industry Leadership Institute Carson School Of Management, Finance & Insurance, University of Minnesota, and Tarren Bragdon, adjunct fellow at the Manhattan Institute and CEO of the Maine Heritage Policy Center, talks to Paul Howard, director of the Center for Medical Progress about "Healthier Choice: An Examination of Market-Based Reforms for New York's Uninsured".


"Only 5 states have Guaranteed Issue and Community Rating and they all have very expensive small individual insurance markets. 35 other states have a much more competitive flexible market…it’s more the case of Congress swimming against the tide of what’s happening in the states." – Tarren Bragdon


RECOMMENDED READING:
"Healthier Choice: An Examination of Market-Based Reforms for New York's Uninsured", Stephen T. Parente and Tarren Bragdon, September 22, 2009



PODCAST:
Scott Harrington, professor of health-care management and insurance and risk management at the University of Pennsylvania's Wharton School and an adjunct scholar at the American Enterprise Institute, talks to Paul Howard, director of the Center for Medical Progress about healthcare co-ops.


"The basic idea is that the government would subsidize at the state or regional level some co-operative health insurance organization.." – Scott Harrington


ADDITIONAL RESOURCES:

LINKS:
http://www.scottharringtonphd.com/

RECOMMENDED READING:
Fact-Checking the President on Health Insurance, Scott Harrington, Wall Street Journal, 9-14-09
Health Co-ops: Slow Road to Government Care, Scott Harrington, Wall Street Journal, 8-19-09
What the States’ Experience with Mandates Should Tell Us about Universal Healthcare Coverage, Scott Harrington, The American, 8-11-09
Reform Needs Healthy Life Incentives, Scott Harrington, Wall Street Journal, 6-29-09
The 'Public Plan' Would Be the Only Plan, Scott Harrington, Wall Street Journal, 6-16-09



PODCAST:
John Cochrane, professor of finance at the University of Chicago and an adjunct fellow at the Cato Institute, talks to Paul Howard, director of the Center for Medical Progress about what to do about preexisting conditions.


"Twenty years ago if you got a long term disease there wasn’t much we could do for you so you weren’t that expensive." – John Cochrane


RECOMMENDED READING:
What to Do About Pre-existing Conditions, John Cochrane, Wall Street Journal, 8-14-09
Health-Status Insurance, John Cochrane, Cato Institute, 2-18-09



PODCAST:
Megan McArdle, is a journalist and blogger for The Atlantic, talks to Paul Howard, director of the Center for Medical Progress about the difference between rationing through price signals in the market and rationing through government agencies.


"The people who are doing the allocation don’t actually have the same incentives as the people for whom they’re doing the rationing." – Megan McArdle


RECOMMENDED READING:
Asymmetrical Information, Megan McArdle’s blog, The Atlantic
Rationing By Any Other Name, Megan McArdle, The Atlantic, 8-10-09


PODCAST:
David Hyman, Director of the Epstein Program in Health Law and Policy at the University of Illinois, talks to Paul Howard, director of the Center for Medical Progress on competition in health insurance markets.


"What makes a market competitive is that there are lots of players in it and none of them have market power, the ability to dictate terms to other participants" – David


RECOMMENDED READING:
Health Insurance: Market Failure or Government Failure?, David A. Hyman , U Illinois Law & Economics Research Paper, April 6, 2009
Malpractice Payouts and Malpractice Insurance, David Hyman, Geneva Papers on Risk and Insurance, 2008



PODCAST:
James Capretta, fellow in the Economics and Ethics Program of the Ethics and Public Policy Center, talks to Paul Howard, director of the Center for Medical Progress, about the most problematic aspects of healthcare legislation on Capitol Hill.


"The bills that are moving in Congress are structurally flawed for one major reason- they essentially force Americans into government approved insurance with the premiums rising at a pretty rapid rate that will be costly for a lot of people” – James Capretta


RECOMMENDED READING:
Obamacare: It's Even Worse Than You Think, Weekly Standard, James C. Capretta and Yuval Levin, 8-3-09
Wrong Big Picture, Dangerous Fine Print, National Review Online, James Capretta and Tevi Troy, 7-31-09
The House Bill Costs Far More Than $1 Trillion, Kaiser Health News, James Capretta, 7-24-09



PODCAST:
David Gratzer, a physician and senior fellow at the Manhattan Institute, talks to Paul Howard, director of the Center for Medical Progress, about the public plan option and what dangers it presents.


“The public plan option would be at an unfair advantage over other plans…it would be reimbursing doctors at a fraction of the price others do” –David Gratzer


RECOMMENDED READING:
'Cost': Health Care's Four-Letter Word, Forbes.com, 07-24-09
Regulation, Not Size, Is Health Care's Biggest Problem, Washington Examiner, 07-22-09
A Medicare-Style Public Option in Healthcare Would Kill Private Insurance, U.S. News and World Report, 07-17-09
Improving Our Tangled Healthcare Mess, The Boston Globe, 07-13-09



PODCAST:
Diana Furchtgott-Roth, an adjunct fellow at the Manhattan Institute and a columnist for RealClearMarkets.com, talks to Paul Howard, director of the Center for Medical Progress, about the Democrats legislation in the House of Representatives to reform healthcare markets.


“What is so frustrating and maddening about this bill is the employers have to provide the same kind of coverage that is in the health exchange plan or the public plan which is a gold plated plan… if employers offered a simple, catastrophic plan…that would not be permitted.”- Diana Furchtgott-Roth


RECOMMENDED READING:
A Very Unhealthy Health Bill, Diana Furchtgott-Roth, RealClearMarkets, 07-16-09
Socialized Medicine Through the Eyes of a Recipient, Diana Furchtgott-Roth, RealClearMarkets, 06-25-09
We Face Major Healthcare Choices, Diana Furchtgott-Roth, RealClearMarkets, 06-04-09



PODCAST:
Elias Zerhouni, senior fellow in the Global Health Program at the Bill and Melinda Gates Foundation and former director the U.S. National Institutes of Health, talks to Paul Howard, director of the Center for Medical Progress, about U.S. leadership in biomedical innovation, the role of innovation in healthcare reform, and what the U.S. can do to ensure that it can remain the leader in biomedical innovation in the 21st century.

PART I | PART II


"It's an era of… precision medicine, no longer can you have a one size fits all type of medicine if you want to be effective in both at providing good healthcare and at a reasonable cost" – Elias Zerhouni


RECOMMENDED READING:
The Promise of Personalized Medicine, NIH Medline Plus, Winter 2007
Extracting Knowledge From Science: A Conversation With Elias Zerhouni, Health Affairs, May/June 2006
Translational and Clinical Science — Time for a New Vision, Elias Zerhouni, New England Journal of Medicine, October 2005



PODCAST:
Gail Wilensky, an economist and a senior fellow at Project HOPE, talks to Paul Howard, director of the Center for Medical Progress, about arguments that the President and members of Congress have made arguing for a public insurance plan to compete with private insurers and what other models are available to improve choice and competition in health insurance markets.


"I believe people who reference the public plan as a way to hold down costs are assuming that the public plan would use the power of a very forceful government to set below market rates as in the case in Medicare and that really is something that would put the private plans at a real disadvantage.” – Gail Wilensky


RECOMMENDED READING:
The Policies And Politics Of Creating A Comparative Clinical Effectiveness Research Center, Gail Wilensky, Business Economics, Gail Wilensky
Reforming Medicare's Physician Payment System, Gail Wilensky, 2-12-09
Value-Based Insurance Design, Michael E. Chernew, Allison B. Rosen and A. Mark Fendrick, 1-30-07



PODCAST:
Stephen Parente, Academic Director, Medical Industry Leadership Institute Carson School Of Management, Finance & Insurance, University of Minnesota, talks to Paul Howard, director of the Center for Medical Progress, about his idea for medical banking.


“No matter what money moves in the healthcare system today, it must go through banks” - Steve Parente


RECOMMENDED READING:
Health Information Technology and Financing’s Next Frontier: The Potential of Medical Banking, Stephen Parente, Business Economics, January 2009



PODCAST:
Joseph Antos, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute, talks to Paul Howard, director of the Center for Medical Progress, about health spending disparities across the U.S. and what they tell us about American healthcare.


“One of the most important things we can do is give patients better information about what is going on” -Joseph Antos


RECOMMENDED READING:
What Can a Texas Town Teach Us About Healthcare?, Joseph Antos, The Enterprise Blog, 6-1-09
The Cost Conundrum, Atul Gawande, The New Yorker, 6-1-09
Obama Targets Wrong Tax for Health Reform, Joseph Antos, the Detroit News, 5-30-09
Uncle Sam, M.D., AEI Scholars on Health Care and Pharmaceutical Reform, April 2009



PODCAST:
Sidney Taurel, former CEO and Chairman of Eli Lilly, talks to Paul Howard, director of the Center for Medical Progress, about the future of the pharmaceutical industry, the future of healthcare, and the importance of thinking of healthcare as an investment in human capital.


RECOMMENDED READING:
From the Broad Brush to the Fine Point: How to Enable Personalized Medicine, Sidney Taurel, 12-12-08



PODCAST:
Betsy McCaughey, Chairman of the Committee to Reduce Infection Deaths and former Lt. Governor of New York State, talks to Paul Howard, director of the Center for Medical Progress, about the truth about healthcare reforms that have been proposed.


“We should not be thinking about healthcare as a cost problem, it’s much more constructive to think of it as a growth industry. . . we’re not in the middle of a healthcare spending crisis."- Betsy McCaughey

RECOMMENDED READING:
Obama's Voodoo Health Economics, Wall Street Journal, 6-5-09
The Attack On Doctors' Hippocratic Oath, Investor’s Business Daily, 4-29-09
Ruin Your Health With the Obama Stimulus Plan: Betsy McCaughey, Bloomberg News, 2-9-09



PODCAST:
Dana Goldman, Senior Principal Researcher at the RAND Corporation, talks to Paul Howard, director of the Center for Medical Progress, about misconceptions on how to cut healthcare costs.


“There’s evidence that would suggest that we’re wasting 30% of our dollars but without knowing which dollar and which is being wasted, you run the risk that if you cut by 30% you will harm people’s health.” – Dana Goldman

RECOMMENDED READING:
Regulating Drug Prices, Dana P. Goldman, Darius N. Lakdawalla, Pierre-Carl Michaud, Neeraj Sood, Robert J. Lempert, Ze Cong,Han de Vries, Italo Gutierrez, January 2009
U.S. Pharmaceutical Policy in a Global Marketplace, Darius N. Lakdawalla, Dana P. Goldman, Pierre-Carl Michaud, Neeraj Sood, Robert J. Lempert, Ze Cong, Han de Vries, Italo Gutierrez, December 16, 2008
The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries, Neeraj Sood, Han de Vries, Italo Gutierrez, Darius N. Lakdawalla, and Dana P. Goldman, December 2008
Life Expectancy Is Better Than Age as a General Predictor of Health Care Expenditures, Baoping Shang, Dana P. Goldman, April 2008
Modeling the Health and Medical Care Spending of the Future Elderly, Dana P. Goldman, David M. Cutler, Paul G. Shekelle, Jay Bhattacharya, Baoping Shang, Geoffrey F. Joyce, Michael Hurd, Dawn Matsui, Sydne Newberry, Constantijn (Stan) Panis, Michael W. Rich, Catherine K. Su, Emmett B. Keeler, Darius N. Lakdawalla, Matthew E. Chernew, Feng Pan, Eduardo Ortiz, Robert H. Brook, A. M. Garber, Shannon Rhodes, 2008
Socioeconomic Differences in the Adoption of New Medical Technologies, D. Goldman and J. Smith, American Economic Review Papers and Proceedings, Vol. 95, No. 2, 2005



PODCAST:
Regina Herzlinger, senior fellow at the Manhattan Institute, talks to Paul Howard, director of the Center for Medical Progress, about the state of the healthcare marketplace in the U.S.


“The first rule of any market is that consumers by things for themselves and that’s violated in healthcare because we have this arcane tax law that promotes agents who do or buy for us.” – Regina Herzlinger

RECOMMENDED READING:
Can the United States Provide Health Care For All?, McKinsey & Company, 05-18-09
Health Care Reform that Will Kill the U.S. Economy, Huffington Post, 04-27-09
Creating a Real Healthcare Market, The Boston Globe, 02-18-09



PODCAST:
Douglas Holtz-Eakin, former CBO director, talks to Paul Howard, director of the Center for Medical Progress, about the principles and priorities policymakers should follow in order to achieve sustainable healthcare reform.


“It should be the case that value and reforms to the delivery system come first, expansion in coverage comes second”- Douglas Holtz-Eakin

RECOMMENDED READING:
Forging a New Plan For Health Care: Principles and Priorities for Sustainable Reform



PODCAST:
Dr. Tom Price, U.S Representative (R-GA), talks to Paul Howard, director of the Center for Medical Progress, about the politics of health reform in Congress and how we can move towards a more patient centered healthcare reform system.


"A lot of the reforms that we talked about seem to make it their goal to make certain that everyone receives exactly the same thing…The problem is that each and every individual patient... is different even though they may have the same diagnosis. What we need is system that is responsive to patients needs and their families needs but is not a cookie cutter kind of system which is what we see in other nations."
— Dr.Tom Price, U.S. Representative (R-GA)

ADDITIONAL RESOURCES

LINKS:
Official Website of Rep. Tom Price
Republican Study Committee

RECOMMENDED READING:
GOP Should Fight Health Care Rationing, Dr. Tom Price, Wall Street Journal, 1-7-09
Getting health care reform right, Dr. Tom Price, Washington Times, 4-1-09
To Reform, Create a Real Marketplace, Dr. Tom Price, Politico, 5-3-09
H.R. 2626: Comprehensive Health Coverage And Reform Enhancement Act of 2007, Rep. Tom Price, 6-7-07



PODCAST:
William Winkenwerder, former assistant secretary of health affairs at the Department of Defense, talks to Paul Howard, director of the Center for Medical Progress, about public and private sector examples of successful health care innovation and what we can learn from them for the debate over health care reform.


"The U.S. has been, far and away, the leader in investment in new medical technologies, new treatments, new pharmaceuticals... and the world has benefited from that."
— Dr. William Winkenwerder, Jr.

ADDITIONAL RESOURCES

RECOMMENDED READING:
The Wrong Stimulus for Health Care, William Winkenwerder, Jr. and Grace-Marie Turner, National Review Online, 02-10-09
Casualties of War—Military Care for the Wounded from Iraq and Afghanistan, Atul Gawande, New England Journal of Medicine, 12-09-04



PODCAST:
Arnold Kling, economist and author, talks to Paul Howard, director of the Center for Medical Progress, about rising health care costs, why insurance now pays for routine health care expenses, and how we can promote innovation and competition in markets dominated by 3rd party payers.


"In this country, 90 percent of personal healthcare spending is paid for by third parties…so that means we are insulated from the financial consequences of our medical decisions."
— Arnold Kling

ADDITIONAL RESOURCES

LINKS:
EconLog
ArnoldKling.com

RECOMMENDED READING:
Insulation vs. Insurance, Arnold Kling, Cato Unbound, 1-8-07
Crisis of Abundance, Arnold Kling, 2006



PODCAST:
Dan Petrylak, associate professor of medicine and director of the genitourinary oncology program at the Columbia University Medical Center, talks to Paul Howard, director of the Center for Medical Progress, about the future of cancer care, and how to make better, more effective treatments a reality.


"Realistically, what we would like to do is to extend life, but to extend life with the best possible quality."
— Dan Petrylak

ADDITIONAL RESOURCES

LINKS:
Project FDA
Cancer Drug Development and Approval
The Cancer Genome Atlas
Medicines in Development for Cancer 2009

RECOMMENDED READING:
Borrow From The HIV Battle Plan To Help Win War Against Cancer, Tomas Philipson, Investor's Business Daily, 03-14-09



PODCAST:
Evan Falchuk, president of Best Doctors, talks to Paul Howard, director of the Center for Medical Progress, about how we define "the best" in health care and how can we leverage individual excellence to drive system wide improvements.


"If you're ill you don't need a Congressional hearing... you just need to get the right diagnosis and treatment and the system should be fixated on that problem not on the particular mechanism of reimbursement"
— Evan Falchuck

ADDITIONAL RESOURCES

LINKS:
Best Doctors: www.bestdoctors.com
See First Blog: www.seefirstblog.com
Atal Gawande: www.gawande.com

RECOMMENDED READING:
Why 'Quality' Care is Dangerous, Jerome Groopman and Pamela Hartzband, Wall Street Journal, 04-08-09


 

MPT on Twitter
MPT on Facebook

Conflict of Interest Regulation

Consumer Driven Health Care

Drug & Medical Device Innovation

Drug & Medical Device Litigation

FDA Regulation

Global Health

Health Care Policy

Intellectual Property
Rights & Innovation

Medicare and Medicaid

Personalized Medicine

Value of Medicine


NEW SECOND OPINION!
Experts Discuss Conflict of Interest Regulation in our "Second Opinion" Expert Forum!

Expert Panel:
  • Jack Calfee
  • Richard Epstein
  • Thomas Huddle
  • Rita Numerof
  • Lance Stell
  • Thomas Stossel
  • Elizabeth Whelan

Click here to read their second opinions.

Project FDA.
  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org